Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 09, 2019

SELL
$15.58 - $20.01 $373,920 - $480,240
-24,000 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $350,160 - $572,160
24,000 New
24,000 $370,000
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $34,813 - $59,210
-3,100 Closed
0 $0
Q3 2017

Nov 02, 2017

BUY
$15.41 - $32.17 $47,771 - $99,727
3,100
3,100 $279,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Vantage Financial Partners Ltd., Inc. Portfolio

Follow Vantage Financial Partners Ltd., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners Ltd., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners Ltd., Inc. with notifications on news.